Abeona therapeutics announces pricing of $75 million underwritten offering of common stock and pre-funded warrants

Cleveland, may 03, 2024 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo) (“abeona” or the “company”) today announced the pricing of an underwritten offering of 12,285,056 shares of its common stock and, in lieu of common stock, pre-funded warrants to purchase 6,142,656 shares of its common stock, at an offering price of $4.07 per share, which is equal to the closing price on thursday, may 2, 2024, or $4.0699 per pre-funded warrant, which represents the per share offering price for the common stock less the $0.0001 per share exercise price for each pre-funded warrant. the pre-funded warrants will be immediately exercisable at a nominal exercise price of $0.0001 per share and may be exercised at any time until the pre-funded warrants are exercised in full. the closing of the offering is expected to occur on or about may 7, 2024, subject to the satisfaction of customary closing conditions.
ABEO Ratings Summary
ABEO Quant Ranking